These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 27521362)

  • 41. Live cytomegalovirus vaccination of renal transplant candidates. A preliminary trial.
    Glazer JP; Friedman HM; Grossman RA; Starr SE; Barker CF; Perloff LJ; Huang ES; Plotkin SA
    Ann Intern Med; 1979 Nov; 91(5):676-83. PubMed ID: 227299
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Normalizing ELISPOT responses to T-cell counts: a novel approach for quantification of HCMV-specific CD4(+) and CD8(+) T-cell responses in kidney transplant recipients.
    Calarota SA; Chiesa A; Scaramuzzi L; Adzasehoun KM; Comolli G; Mangione F; Esposito P; Baldanti F
    J Clin Virol; 2014 Sep; 61(1):65-73. PubMed ID: 24961915
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Randomized, double-blind, Phase 1 trial of an alphavirus replicon vaccine for cytomegalovirus in CMV seronegative adult volunteers.
    Bernstein DI; Reap EA; Katen K; Watson A; Smith K; Norberg P; Olmsted RA; Hoeper A; Morris J; Negri S; Maughan MF; Chulay JD
    Vaccine; 2009 Dec; 28(2):484-93. PubMed ID: 19857446
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Update on the current status of cytomegalovirus vaccines.
    Sung H; Schleiss MR
    Expert Rev Vaccines; 2010 Nov; 9(11):1303-14. PubMed ID: 21087108
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Human Cytomegalovirus Particles Treated with Specific Antibodies Induce Intrinsic and Adaptive but Not Innate Immune Responses.
    Wu Z; Qin R; Wang L; Bosso M; Scherer M; Stamminger T; Hotter D; Mertens T; Frascaroli G
    J Virol; 2017 Nov; 91(22):. PubMed ID: 28878085
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Multicenter trial of Towne strain attenuated virus vaccine in seronegative renal transplant recipients.
    Plotkin SA; Higgins R; Kurtz JB; Morris PJ; Campbell DA; Shope TC; Spector SA; Dankner WM
    Transplantation; 1994 Dec; 58(11):1176-8. PubMed ID: 7992358
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Humoral immune response to cytomegalovirus Towne vaccine strain and to Toledo low-passage strain.
    Gönczöl E; Ianacone J; Furlini G; Ho W; Plotkin SA
    J Infect Dis; 1989 May; 159(5):851-9. PubMed ID: 2540246
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dendritic cell vaccination in allogeneic stem cell recipients: induction of human cytomegalovirus (HCMV)-specific cytotoxic T lymphocyte responses even in patients receiving a transplant from an HCMV-seronegative donor.
    Grigoleit GU; Kapp M; Hebart H; Fick K; Beck R; Jahn G; Einsele H
    J Infect Dis; 2007 Sep; 196(5):699-704. PubMed ID: 17674311
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ad-gBCMVpoly: A novel chimeric vaccine strategy for human cytomegalovirus-associated diseases.
    Zhong J; Khanna R
    J Clin Virol; 2009 Dec; 46 Suppl 4():S68-72. PubMed ID: 19646921
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The development of Chinese specific human cytomegalovirus polyepitope recombinant vaccine.
    Zhao P; Ma DX; Yu S; Xue FZ; Zhu WW; Shao N; Zhang JR; Ji CY
    Antiviral Res; 2012 Feb; 93(2):260-269. PubMed ID: 22197248
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dendritic cell vaccination in an allogeneic stem cell recipient receiving a transplant from a human cytomegalovirus (HCMV)-seronegative donor: induction of a HCMV-specific T(helper) cell response.
    Feuchtinger T; Opherk K; Bicanic O; Schumm M; Grigoleit GU; Hamprecht K; Jahn G; Handgretinger R; Lang P
    Cytotherapy; 2010 Nov; 12(7):945-50. PubMed ID: 20230226
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Reconstitution of Human Cytomegalovirus-Specific CD4+ T Cells is Critical for Control of Virus Reactivation in Hematopoietic Stem Cell Transplant Recipients but Does Not Prevent Organ Infection.
    Gabanti E; Lilleri D; Ripamonti F; Bruno F; Zelini P; Furione M; Colombo AA; Alessandrino EP; Gerna G
    Biol Blood Marrow Transplant; 2015 Dec; 21(12):2192-2202. PubMed ID: 26260678
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Neutralizing activity of saliva against cytomegalovirus.
    Saccoccio FM; Gallagher MK; Adler SP; McVoy MA
    Clin Vaccine Immunol; 2011 Sep; 18(9):1536-42. PubMed ID: 21795465
    [TBL] [Abstract][Full Text] [Related]  

  • 54. T cell proliferative responses to five human cytomegalovirus proteins in healthy seropositive individuals: implications for vaccine development.
    He H; Rinaldo CR; Morel PA
    J Gen Virol; 1995 Jul; 76 ( Pt 7)():1603-10. PubMed ID: 9049367
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prospects of a vaccine for the prevention of congenital cytomegalovirus disease.
    Plachter B
    Med Microbiol Immunol; 2016 Dec; 205(6):537-547. PubMed ID: 27519596
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Human cytomegalovirus vaccine development: Immune responses to look into vaccine strategy.
    Xia L; Su R; An Z; Fu TM; Luo W
    Hum Vaccin Immunother; 2018 Feb; 14(2):292-303. PubMed ID: 29053403
    [TBL] [Abstract][Full Text] [Related]  

  • 57. DNA vaccines expressing glycoprotein complex II antigens gM and gN elicited neutralizing antibodies against multiple human cytomegalovirus (HCMV) isolates.
    Shen S; Wang S; Britt WJ; Lu S
    Vaccine; 2007 Apr; 25(17):3319-27. PubMed ID: 17287056
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A novel therapeutic cytomegalovirus DNA vaccine in allogeneic haemopoietic stem-cell transplantation: a randomised, double-blind, placebo-controlled, phase 2 trial.
    Kharfan-Dabaja MA; Boeckh M; Wilck MB; Langston AA; Chu AH; Wloch MK; Guterwill DF; Smith LR; Rolland AP; Kenney RT
    Lancet Infect Dis; 2012 Apr; 12(4):290-9. PubMed ID: 22237175
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Human cytomegalovirus particles directly suppress CD4 T-lymphocyte activation and proliferation.
    Fornara O; Odeberg J; Khan Z; Stragliotto G; Peredo I; Butler L; Söderberg-Nauclér C
    Immunobiology; 2013 Aug; 218(8):1034-40. PubMed ID: 23434301
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A replication-defective human cytomegalovirus vaccine for prevention of congenital infection.
    Wang D; Freed DC; He X; Li F; Tang A; Cox KS; Dubey SA; Cole S; Medi MB; Liu Y; Xu J; Zhang ZQ; Finnefrock AC; Song L; Espeseth AS; Shiver JW; Casimiro DR; Fu TM
    Sci Transl Med; 2016 Oct; 8(362):362ra145. PubMed ID: 27797961
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.